(Total Views: 711)
Posted On: 08/01/2020 1:57:07 PM
Post# of 154130
Re: craigakess #46566
I DISAGREE 100% (yelling intended).
The Primary endpoint for Renegeron's REGN10933+REGN10987 trials is SAEs.
(https://clinicaltrials.gov/ct2/show/NCT04426695?term=regeneron+covid&draw=2&rank=3
If you/your wife/husband/child/brother/sister were mildly sick with covid, which is more important?
Persistence of cough at 14 days
or
Serious Adverse Events
I'll deal with the cough
The 64% reduction in SAEs is by itself a result. I have no more money to buy any more stock, but I would if I could.
As one investing blogger wrote (wish I remembered where), after these SAE results we know that Leronlimab won the game, we just don't know the score.
The Primary endpoint for Renegeron's REGN10933+REGN10987 trials is SAEs.
(https://clinicaltrials.gov/ct2/show/NCT04426695?term=regeneron+covid&draw=2&rank=3
If you/your wife/husband/child/brother/sister were mildly sick with covid, which is more important?
Persistence of cough at 14 days
or
Serious Adverse Events
I'll deal with the cough
The 64% reduction in SAEs is by itself a result. I have no more money to buy any more stock, but I would if I could.
As one investing blogger wrote (wish I remembered where), after these SAE results we know that Leronlimab won the game, we just don't know the score.
(7)
(0)
